Cargando…
Overview of the potential use of fluvoxamine for COVID-19 and long COVID
Coronavirus disease 2019 (COVID-19) has presented a serious worldwide threat to public health since its emergence in late 2019. From a safety point of view, drug repurposing has received particular attention. Several clinical studies have demonstrated that the use of fluvoxamine, a selective seroton...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029802/ https://www.ncbi.nlm.nih.gov/pubmed/36968793 http://dx.doi.org/10.1007/s44192-023-00036-3 |